Differences
This shows you the differences between two versions of the page.
| — | medicine-overpricing-complaint-india [2026/07/22 17:47] (current) – created - external edit 127.0.0.1 | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| + | ====== Medicine Overpricing Complaint Guide — NPPA, DPCO 2013 (2026) ====== | ||
| + | |||
| + | |||
| + | |||
| + | {{ : | ||
| + | |||
| + | <WRAP center round info 95%> | ||
| + | **Quick Reply:** Pharmacy charging above MRP or scheduled price? NPPA + DPCO 2013 + CCPA + e-Daakhil consumer court — citizen recovery guide 2026. | ||
| + | </ | ||
| + | |||
| + | {{htmlmetatags> | ||
| + | {{htmlmetatags> | ||
| + | |||
| + | A senior citizen in Chennai is charged ₹780 for a medicine whose Maximum Retail Price under DPCO 2013 is ₹450, and the pharmacy says " | ||
| + | |||
| + | > **Citizen Crisis Response Network — medicine overpricing checklist**\\ Verify medicine on **NPPA price list** at [[https:// | ||
| + | |||
| + | ===== Direct answer (featured snippet) ===== | ||
| + | |||
| + | To dispute medicine overpricing in India: (1) check whether the medicine is **DPCO 2013 scheduled** at [[https:// | ||
| + | |||
| + | ===== In this guide ===== | ||
| + | |||
| + | * [[#How drug pricing works in India|How drug pricing works in India]] | ||
| + | * [[#DPCO 2013 — what's scheduled|DPCO 2013 — what's scheduled]] | ||
| + | * [[# | ||
| + | * [[#Common overpricing violations|Common overpricing violations]] | ||
| + | * [[#The 7-day complaint escalation|The 7-day complaint escalation]] | ||
| + | * [[#Generics + Jan Aushadhi + CGHS pricing|Generics + Jan Aushadhi + CGHS pricing]] | ||
| + | * [[#Sample complaint + NPPA filing|Sample complaint + NPPA filing]] | ||
| + | * [[#Filing an RTI to NPPA / Drugs Controller|Filing an RTI to NPPA / Drugs Controller]] | ||
| + | * [[# | ||
| + | * [[#Myth vs reality|Myth vs reality]] | ||
| + | |||
| + | ===== How drug pricing works in India ===== | ||
| + | |||
| + | ==== Three categories ==== | ||
| + | |||
| + | * **Scheduled medicines (DPCO 2013)**: ~384 essential medicines with statutory MRP fixed by NPPA. | ||
| + | * **Unscheduled medicines**: | ||
| + | * **New launches**: NPPA monitors first-launch pricing. | ||
| + | |||
| + | ==== MRP printing ==== | ||
| + | |||
| + | Mandatory under Drugs and Cosmetics Act 1940. Anything above MRP = criminal. | ||
| + | |||
| + | ==== GST on medicines ==== | ||
| + | |||
| + | * Life-saving / oncology: 5%. | ||
| + | * General: 12%. | ||
| + | * Premium / non-essential: | ||
| + | |||
| + | GST is on the MRP base, not in addition. | ||
| + | |||
| + | ===== DPCO 2013 — what's scheduled ===== | ||
| + | |||
| + | ==== Categories of scheduled drugs ==== | ||
| + | |||
| + | * Essential cancer drugs. | ||
| + | * Cardiac (statins, beta-blockers). | ||
| + | * Antibiotics (penicillin, | ||
| + | * Anti-diabetic (insulin, metformin, glimepiride). | ||
| + | * Anti-hypertensive. | ||
| + | * Anti-tuberculosis. | ||
| + | * Anti-malarial. | ||
| + | * Anti-asthmatic. | ||
| + | * Vaccines. | ||
| + | * Pediatric drugs. | ||
| + | |||
| + | ==== How to verify ==== | ||
| + | |||
| + | NPPA portal: [[https:// | ||
| + | |||
| + | ==== Penalty ==== | ||
| + | |||
| + | * **Sale above MRP**: **₹50,000 per offence + 1 year imprisonment** under DPCO 2013. | ||
| + | * **Repeat**: ₹1 lakh + 7 years imprisonment. | ||
| + | * **Refund + compensation** to affected customer. | ||
| + | |||
| + | ===== NPPA's role + price-fixing process ===== | ||
| + | |||
| + | ==== National Pharmaceutical Pricing Authority (NPPA) ==== | ||
| + | |||
| + | Statutory body since 1997 under Department of Pharmaceuticals. | ||
| + | |||
| + | ==== Powers ==== | ||
| + | |||
| + | * Fix and revise scheduled medicines MRP. | ||
| + | * Investigate complaints. | ||
| + | * Penalty under DPCO + EC Act. | ||
| + | * Audit pharmaceutical companies. | ||
| + | * Recall medicines. | ||
| + | |||
| + | ==== Price fixing methodology ==== | ||
| + | |||
| + | * **Cost-Plus method** (older). | ||
| + | * **Market-based simple-average** (current — average of brands with >1% market share). | ||
| + | * **Annual revision** capped at WPI increase. | ||
| + | |||
| + | ==== Challenge before court ==== | ||
| + | |||
| + | Pharma companies can challenge NPPA fixings before High Court / Supreme Court. | ||
| + | |||
| + | ===== Common overpricing violations ===== | ||
| + | |||
| + | * **Charging above MRP** (any medicine). | ||
| + | * **Charging above NPPA ceiling** (scheduled medicines). | ||
| + | * **GST stacking** on MRP-inclusive packages. | ||
| + | * **" | ||
| + | * **Hidden charges**: cold storage, packaging, "gift wrapping." | ||
| + | * **Bundled pricing** without itemised breakup. | ||
| + | * **Substandard / repackaged** at premium. | ||
| + | * **Expired sold at MRP**. | ||
| + | * **Higher rate** than physical retail. | ||
| + | |||
| + | ===== The 7-day complaint escalation ===== | ||
| + | |||
| + | - **Day 0**: Photograph bill + medicine MRP + NPPA verification. | ||
| + | - **Day 1**: Demand refund at pharmacy. | ||
| + | - **Day 3**: NPPA filing + state Drugs Controller. | ||
| + | - **Day 7**: NCH 1915 + e-Daakhil consumer court. | ||
| + | - **Day 14**: Legal Metrology complaint. | ||
| + | - **Day 30**: CCPA for systemic. | ||
| + | |||
| + | ===== Generics + Jan Aushadhi + CGHS pricing ===== | ||
| + | |||
| + | ==== Generic medicines ==== | ||
| + | |||
| + | Same active ingredient as brand at significantly lower price (typically 50-80% cheaper). | ||
| + | |||
| + | ==== Jan Aushadhi Kendras ==== | ||
| + | |||
| + | Government-run pharmacies selling generic medicines at <50% of brand price. Locator: [[https:// | ||
| + | |||
| + | ==== CGHS pricing ==== | ||
| + | |||
| + | Central Government Health Scheme procurement rates often 30-60% below market. Reference for fairness assessment. | ||
| + | |||
| + | ==== Free Care via PMJAY / Ayushman Bharat ==== | ||
| + | |||
| + | Hospital expenditure including medicines covered under empaneled hospitals. | ||
| + | |||
| + | ==== Demand generic substitution ==== | ||
| + | |||
| + | * Doctor' | ||
| + | * Pharmacist required to inform of cheaper generic alternative. | ||
| + | |||
| + | ===== Sample complaint + NPPA filing ===== | ||
| + | |||
| + | ==== Pharmacy demand letter ==== | ||
| + | |||
| + | < | ||
| + | To: The Manager | ||
| + | [Pharmacy Name] | ||
| + | [Address] | ||
| + | DD-MM-2026 | ||
| + | |||
| + | Sub: Demand for refund — overpricing of [Medicine Name] | ||
| + | bill no. _______ dated DD-MM-2026 | ||
| + | |||
| + | Sir / Madam, | ||
| + | |||
| + | On DD-MM-2026 I purchased [Medicine Name] [Strength] | ||
| + | [Pack size] from your pharmacy at ₹__________. | ||
| + | |||
| + | NPPA notified ceiling price for this medicine | ||
| + | under DPCO 2013 is ₹__________ (Annexure A — | ||
| + | NPPA portal screenshot dated DD-MM-2026). | ||
| + | |||
| + | Excess charged: ₹__________. | ||
| + | |||
| + | I demand refund within 7 days. | ||
| + | |||
| + | Failing compliance: | ||
| + | (i) NPPA filing. | ||
| + | (ii) State Drugs Controller complaint. | ||
| + | (iii) Legal Metrology complaint. | ||
| + | (iv) NCH 1915 + e-Daakhil consumer court. | ||
| + | (v) CCPA filing. | ||
| + | (vi) FIR under DPCO + EC Act. | ||
| + | |||
| + | [Name, contact, bill no.] | ||
| + | </ | ||
| + | |||
| + | ==== NPPA filing ==== | ||
| + | |||
| + | [[https:// | ||
| + | |||
| + | Documents: | ||
| + | * Bill copy. | ||
| + | * Medicine package photo (showing MRP + batch). | ||
| + | * NPPA price-list comparison. | ||
| + | * Pharmacy details (GST, FSSAI, drug licence). | ||
| + | |||
| + | NPPA action: 30-90 day investigation. Penalty + refund order. | ||
| + | |||
| + | ===== Filing an RTI to NPPA / Drugs Controller ===== | ||
| + | |||
| + | < | ||
| + | PIO, NPPA / Central Drugs Standard Control Organization (CDSCO) | ||
| + | / State Drugs Controller | ||
| + | |||
| + | Sub: Application under §6(1) RTI Act 2005 | ||
| + | |||
| + | Please furnish: | ||
| + | |||
| + | 1. Whether [Medicine Name] [Strength] [Formulation] | ||
| + | is a scheduled medicine under DPCO 2013, and the | ||
| + | | ||
| + | |||
| + | 2. Number of complaints received against [Pharmacy | ||
| + | Name] in last 24 months and action taken. | ||
| + | |||
| + | 3. Drug licence status of the pharmacy + last | ||
| + | | ||
| + | |||
| + | 4. Number of show-cause / closure orders issued in | ||
| + | the state in last 24 months for medicine | ||
| + | | ||
| + | |||
| + | 5. The Drug Inspector for the area. | ||
| + | |||
| + | A reply is requested under §7(1) within 30 days. | ||
| + | |||
| + | [Name, contact] | ||
| + | DD-MM-2026 | ||
| + | </ | ||
| + | |||
| + | ==== Case-law touchpoints ==== | ||
| + | |||
| + | //Cipla Ltd v. UoI// (Supreme Court 2017) — DPCO upheld. //Pfizer v. UoI// (Delhi HC 2024) — pricing methodology. //All India Drug Action Network v. UoI// (multiple writ petitions) — price control enforcement. //State of Maharashtra v. Pharma Distributor// | ||
| + | |||
| + | ===== Sources & internal links ===== | ||
| + | |||
| + | * **NPPA** — nppa.gov.in | ||
| + | * **CDSCO** — cdsco.gov.in | ||
| + | * **State Drugs Controllers** | ||
| + | * **Jan Aushadhi** — janaushadhi.gov.in | ||
| + | * **NCH** — consumerhelpline.gov.in · 1915 | ||
| + | * **CCPA** — consumeraffairs.nic.in | ||
| + | * **DCDRC / e-Daakhil** — e-jagriti.gov.in | ||
| + | * **Legal Metrology departments** | ||
| + | * **DPCO 2013** | ||
| + | * **Essential Commodities Act 1955** — §7 | ||
| + | * **Drugs and Cosmetics Act 1940** | ||
| + | * **CPA 2019** — §2(11), §35 | ||
| + | |||
| + | Useful RTI Wiki tools: | ||
| + | |||
| + | * [[https:// | ||
| + | * [[https:// | ||
| + | * [[https:// | ||
| + | * [[https:// | ||
| + | |||
| + | ===== FAQ ===== | ||
| + | |||
| + | ==== How do I know if a medicine is scheduled? ==== | ||
| + | |||
| + | NPPA portal lookup. About 384 medicines listed. | ||
| + | |||
| + | ++++ Pharmacy says " | ||
| + | For scheduled medicines, MRP is the ceiling regardless of brand. Different brands may have different MRPs but all capped. | ||
| + | ==== ++++ Generic vs brand — same medicine? ==== | ||
| + | |||
| + | Same active ingredient, manufactured differently, | ||
| + | |||
| + | ==== Jan Aushadhi runs out — pharmacy charge MRP? ==== | ||
| + | |||
| + | Jan Aushadhi has limited stock. If unavailable, | ||
| + | |||
| + | ==== Doctor refused generic prescription. Can I still ask? ==== | ||
| + | |||
| + | Pharmacist required to inform of cheaper generic alternative under most state pharmacy laws. | ||
| + | |||
| + | ==== Online pharmacy (1mg, NetMeds) overcharged — recourse? ==== | ||
| + | |||
| + | Same NPPA + DPCO rules apply. Online platform' | ||
| + | |||
| + | ==== Insurance covers medicines — does overpricing affect? ==== | ||
| + | |||
| + | Yes, insurance reimbursement is based on bill. Inflated bills = false claim. | ||
| + | |||
| + | ==== Free hospital medicines under Ayushman Bharat — overcharged? | ||
| + | |||
| + | Hospital cannot charge separately for empaneled-hospital schemes. Report to PMJAY grievance. | ||
| + | |||
| + | ==== Imported medicines — different rules? ==== | ||
| + | |||
| + | Same DPCO if scheduled. Customs + CDSCO regulate imports. | ||
| + | |||
| + | ==== Pharmacy refused to issue bill — what now? ==== | ||
| + | |||
| + | Bill demand under Drugs and Cosmetics Act. State Drugs Controller can compel. | ||
| + | |||
| + | ===== Myth vs reality ===== | ||
| + | |||
| + | ^ Myth ^ Reality ^ | ||
| + | | " | ||
| + | | " | ||
| + | | " | ||
| + | | "NPPA doesn' | ||
| + | | "Jan Aushadhi has limited drugs." | ||
| + | | " | ||
| + | |||
| + | {{tag> | ||